All Stories

  1. Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study
  2. Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways
  3. Brain NMDA Receptors in Schizophrenia and Depression
  4. Antidepressant-Like Effects of CX717, a Positive Allosteric Modulator of AMPA Receptors
  5. β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System
  6. Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
  7. Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist
  8. Brain oscillations after deep brain stimulation for depression
  9. The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression
  10. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action
  11. Is the Acute NMDA Receptor Hypofunction a Valid Model of Schizophrenia?
  12. Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists
  13. Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia
  14. In Vitro and In Vivo Activation of Astrocytes by Amyloid-β is Potentiated by Pro-Oxidant Agents
  15. Editorial [Hot topic: New Strategies in the Search of Antipsychotic Drugs (Executive Editor: Albert Adell)]
  16. Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex
  17. Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats
  18. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action
  19. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain
  20. Clozapine and Haloperidol Differently Suppress the MK-801-Increased Glutamatergic and Serotonergic Transmission in the Medial Prefrontal Cortex of the Rat
  21. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex
  22. Pindolol Augmentation of Antidepressant Response
  23. Chapter 6.3 The use of brain microdialysis in antidepressant drug research
  24. Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine
  25. Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex
  26. Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease
  27. Strategies for producing faster acting antidepressants
  28. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems
  29. Antidepressant Properties of Substance P Antagonists: Relationship to Monoaminergic Mechanisms?
  30. Co-expression and In Vivo Interaction of Serotonin1A and Serotonin2A Receptors in Pyramidal Neurons of Prefrontal Cortex
  31. Stimulation of α1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs
  32. In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT2A receptors: effect of antipsychotic drugs
  33. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei
  34. How does pindolol improve antidepressant action?
  35. Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents
  36. Simultaneous comparison of cerebral dialysis and push–pull perfusion in the brain of rats: a critical review
  37. Comparative Study in the Rat of the Actions of Different Types of Stress on the Release of 5-HT in Raphe Nuclei and Forebrain Areas
  38. Lesioning of midbrain raphe nuclei with 5,7-DHT fails to alter ethanol intake in the low alcohol drinking (LAD) rat
  39. Action of harman (1-methyl-β-carboline) on the brain: Body temperature and in vivo efflux of 5-HT from hippocampus of the rat
  40. Selective destruction of midbrain raphe nuclei by 5,7-DHT: is brain 5-HT involved in alcohol drinking in Sprague-Dawley rats?
  41. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism: Epitome of cerebral complexity
  42. 5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman
  43. Increased alcohol intake in low alcohol drinking rats after chronic infusion of the β-carboline harman into the hippocampus
  44. The Raphe nuclei as a preferential target for antidepressant drugs acting on the 5-HT system: in vivo microdialysis studies in freely-moving rats
  45. Regional Distribution of Extracellular 5-Hydroxytryptamine and 5-Hydroxyindoleacetic Acid in the Brain of Freely Moving Rats
  46. Non-specific inhibition of imipramine binding argues against an endogenous ligand
  47. Chronic administration of clomipramine prevents the increase in serotonin and noradrenaline induced by chronic stress
  48. Time course of changes in serotonin and noradrenaline in rat brain after predictable or unpredictable shock
  49. Quantitation of total MHPG in the rat brain using a non enzymatic hydrolysis procedure. Effects of drugs
  50. Experimental Research